Ally Bridge Group (Ny) LLC Adicet Bio, Inc. Transaction History

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$13.43 - $18.74 $3.28 Million - $4.58 Million
244,400 New
244,400 $3.48 Million
Q4 2021

Feb 14, 2022
SELL
$7.37 - $17.49 $3.13 Million - $7.43 Million
-425,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$12.12 - $17.17 $5.15 Million - $7.3 Million
425,000 New
425,000 $5.56 Million

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $39.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email